Mickaël Derangeon, Véronique Bozon, Norah Defamie, Nicolas Peineau, Nicolas Bourmeyster, Denis Sarrouilhe, Jorge A Argibay, Jean-Claude Hervé
Index: J. Mol. Cell. Cardiol. 48(1) , 220-9, (2010)
Full Text: HTML
5-hydroxytryptamine-4 (5-HT(4)) receptors have been proposed to contribute to the generation of atrial fibrillation in human atrial myocytes, but it is unclear if these receptors are present in the hearts of small laboratory animals (e.g. rat). In this study, we examined presence and functionality of 5-HT(4) receptors in auricular myocytes of newborn rats and their possible involvement in regulation of gap junctional intercellular communication (GJIC, responsible for the cell-to-cell propagation of the cardiac excitation). Western-blotting assays showed that 5-HT(4) receptors were present and real-time RT-PCR analysis revealed that 5-HT(4b) was the predominant isoform. Serotonin (1 microM) significantly reduced cAMP concentration unless a selective 5-HT(4) inhibitor (GR113808 or ML10375, both 1 microM) was present. Serotonin also reduced the amplitude of L-type calcium currents and influenced the strength of GJIC without modifying the phosphorylation profiles of the different channel-forming proteins or connexins (Cxs), namely Cx40, Cx43 and Cx45. GJIC was markedly increased when serotonin exposure occurred in presence of a 5-HT(4) inhibitor but strongly reduced when 5-HT(2A) and 5-HT(2B) receptors were inhibited, showing that activation of these receptors antagonistically regulated GJIC. The serotoninergic response was completely abolished when 5-HT(4), 5-HT(2A) and 5-HT(2B) were simultaneously inhibited. A 24 h serotonin exposure strongly reduced Cx40 expression whereas Cx45 was less affected and Cx43 still less. In conclusion, this study revealed that 5-HT(4) (mainly 5-HT(4b)), 5-HT(2A) and 5-HT(2B) receptors coexisted in auricular myocytes of newborn rat, that 5-HT(4) activation reduced cAMP concentration, I(Ca)(L) and intercellular coupling whereas 5-HT(2A) or 5-HT(2B) activation conversely enhanced GJIC.Copyright 2009 Elsevier Inc. All rights reserved.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
GR113808
CAS:144625-51-4 |
C19H27N3O4S |
Novel antagonists of serotonin-4 receptors: synthesis and bi...
2009-03-15 [Bioorg. Med. Chem. 17 , 2607-2622, (2009)] |
Dual role of serotonin in the pathogenesis of indomethacin-i...
2012-09-01 [Pharmacol. Res. 66(3) , 226-34, (2012)] |
Molecular characterization of a purified 5-HT4 receptor: a s...
2005-05-27 [J. Biol. Chem. 280(21) , 20253-60, (2005)] |
A 5-HT4 agonist, mosapride, enhances intrinsic rectorectal a...
2005-08-01 [Am. J. Physiol. Gastrointest. Liver Physiol. 289(2) , G351-60, (2005)] |
Electrophysiological effects of prucalopride, a novel entero...
2005-04-01 [J. Pharmacol. Exp. Ther. 313(1) , 146-53, (2005)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved